Funding for this research was provided by:
Swedish Science Council (VR2012-3523)
Health & Medical Care Committee of the Regional Executive Board of the Region Västra Götaland
King Gustaf V’s and Queen Victoria’s Freemasons´ Foundation
Swedish National Stroke Association
Local Research and Development Board for Gothenburg and Södra Bohuslän
Agneta Prytz-Folke’s Gösta Folke’s Foundation
Wilhelm & Martina Lundgrens Foundation
Felix Neubergh´s Foundation
Hjalmar Svensson´s Research Foundation
Rune and Ulla Amlöv´s Foundation
John and Berit Wennerström´s Foundation
Text and Data Mining valid from 2019-11-09
Received: 29 May 2019
Accepted: 20 October 2019
First Online: 9 November 2019
Ethics approval and consent to participate
: Ethical approval for the trial was granted by the Regional Ethical Review Board in Gothenburg (reference number: 042–11), and the Helsinki declaration was followed. The patients were informed by a research coordinator about the study and asked if they wanted to participate. Written informed consent was obtained from the participants or from their closest relative.
: Not applicable.
: The authors declare that they have no competing interests.